Figure 7.
Analysis of cell cycle perturbation in human cancer cell lines treated with Sora, Kmf and their simultaneous combination. (A) Hep3b and (B) HepG2 hepatic cancer cell lines were either left untreated or treated with Sora (5 μM), Kmf (200 μM), Kmf (400 μM), or simultaneous combinations of Sora and Kmf (5 μM + 200 μM) or (5 μM + 400 μM) for 72 h. At least three samples were analyzed and 20,000 events were scored for each sample. The vertical axis represents the relative number of events and the horizontal axis represents the fluorescence intensity. The black and white curves are for control and experimental groups, respectively. Sora, sorafenib; Kmf, kaempferol; UT, untreated.
